Lasting heart concerns in kids post-MIS-C: Study urges ongoing cardiac checks

Researchers evaluated the long-term cardiovascular effects in children after treatment for MIS-C, a condition linked to COVID-19. They found that regardless of initial heart injury, most children displayed persistent cardiac abnormalities, underscoring the importance of ongoing cardiac monitoring post-recovery.

Jazz Pharmaceuticals CEO and co-founder Bruce Cozadd is retiring

Jazz Pharmaceuticals CEO Bruce Cozadd is ready to play his outro. On Monday, Cozadd announced plans to retire, nearly 22 years … Sign up to

December 18, 2024

FDA accepts Deciphera’s vimseltinib NDA for priority review

The asset is intended at treating tenosynovial giant cell tumours. Credit: Gorodenkoff via Shutterstock. The US Food and Drug Administration (FDA) has accepted for priority

August 16, 2024

Johnson & Johnson’s Q2 2024 net earnings drop 12.8% to $4.6bn

In the US, the reported sales of Johnson & Johnson surged by 7.8% to $12.5bn compared to $11.6bn in Q2 2023. Credit: josefkubes / Shutterstock.

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.